Valuation: Simcere Pharmaceutical Group Limited

Market Cap 3.78B 29.61B 3.24B 3.03B 2.77B 5.23B 360B 5.28B 35.78B 13.93B 182B 14.18B 13.88B 602B P/E 2026 *
14.4x
P/E 2027 * 12.5x
Enterprise Value 3.58B 28.06B 3.07B 2.87B 2.63B 4.96B 341B 5B 33.91B 13.2B 172B 13.44B 13.15B 570B EV / Sales 2026 *
2.38x
EV / Sales 2027 * 2.15x
Free-Float
32.13%
Yield 2026 *
3.65%
Yield 2027 * 4.14%
1 day+0.61%
1 week-4.68%
Current month-6.07%
1 month-8.08%
3 months+12.95%
6 months-3.49%
Current year-3.09%
1 week 11.34
Extreme 11.34
12.82
1 month 11.34
Extreme 11.34
13.12
Current year 9.07
Extreme 9.07
14.28
1 year 9.07
Extreme 9.07
14.55
3 years 4.94
Extreme 4.94
15.08
5 years 4.94
Extreme 4.94
15.08
10 years 4.94
Extreme 4.94
15.08
Manager TitleAgeSince
Chief Executive Officer 63 20/08/2026
Chief Executive Officer 54 25/03/2026
Director of Finance/CFO 55 19/11/2019
Director TitleAgeSince
Chairman 63 08/10/2012
Director/Board Member 55 19/11/2019
Director/Board Member 46 01/11/2019
Date Insider Type Main position Quantity % Market Cap.
13/07/26 Other

Founder

-47,000 0.0018%
13/07/26 Other

Director

-47,000 0.0018%
10/07/26 Other

Founder

-53,000 0.0021%
Change 5-day change 1-year change 3-year change Capi.($)
+0.61%-4.68%-19.67%+88.31% 3.78B
-1.17%-0.03%+18.70%+70.05% 48.37B
+1.12%+1.41%+54.88%+122.68% 39.88B
-1.36%-1.36%-11.21%+14.14% 12.05B
+2.27%+4.12%+16.41%+81.30% 11.77B
+0.19%0.00%+30.98%+150.00% 9.19B
-0.82%+2.87%+24.06%+44.81% 7.87B
+1.30%+1.26%+54.43%-10.73% 7.25B
+1.60%+8.54%+25.00%+217.84% 7.1B
+0.95%-8.22%-39.88%+16.67% 5.26B
Average +0.47%-0.14%+15.37%+79.51% 15.25B
Weighted average by Cap. +0.14%+0.95%+25.66%+85.43%

Financials

2026 *2027 *
Net sales 1.5B 11.77B 1.29B 1.21B 1.1B 2.08B 143B 2.1B 14.22B 5.53B 72.21B 5.64B 5.51B 239B 1.69B 13.26B 1.45B 1.36B 1.24B 2.34B 161B 2.37B 16.03B 6.24B 81.38B 6.35B 6.21B 270B
Net income 255M 2B 219M 205M 187M 353M 24.33B 357M 2.42B 941M 12.28B 958M 938M 40.66B 302M 2.36B 258M 242M 221M 418M 28.76B 422M 2.86B 1.11B 14.51B 1.13B 1.11B 48.05B
Net Debt -197M -1.55B -169M -158M -145M -273M -18.81B -276M -1.87B -727M -9.49B -741M -725M -31.43B -140M -1.1B -120M -112M -102M -193M -13.32B -195M -1.32B -515M -6.72B -525M -513M -22.26B
Logo Simcere Pharmaceutical Group Limited
Simcere Pharmaceutical Group Ltd is a company engaged in research and development, production and sales of drugs. The Company's main products are generic drugs, including Bicun used for central nervous system diseases, Jepaso and Jiebaili used for oncology, as well as Yingtaiqing used for autoimmune diseases. The Company also produces various drugs, including Endostar used for oncology. The Company is also involved in providing promotion services for third-party drugs sold by medical institutions. The Company mainly conducts its businesses in the domestic market and overseas markets.
Employees
7,064
Date Price Change Volume
26/08/26 HK$11.60 +0.61% 5,882,000
25/08/26 HK$11.53 -0.60% 5,952,643
24/08/26 HK$11.60 -3.97% 5,191,643
21/08/26 HK$12.08 -0.98% 7,444,000
20/08/26 HK$12.20 +0.25% 14,074,000
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
9.887CNY
Average target price
15.11CNY
Spread / Average Target
+52.85%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2096 Stock